Nicholas James Ashton
Göteborgs universitet
H-index: 57
Europe-Sweden
Top articles of Nicholas James Ashton
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer's disease | medRxiv | Vijay Varma An Yang PrzemysĹ ‚aw RadosĹ ‚aw Kac Murat Bilgel Abhay Moghekar | 2024 |
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort | Journal of Neurology | Augusto J Mendes Federica Ribaldi Aurelien Lathuiliere Nicholas J Ashton Shorena Janelidze | 2024/1/9 |
Biomarker-based staging of Alzheimer disease: rationale and clinical applications | Joseph Therriault Suzanne E Schindler Gemma Salvadó Tharick A Pascoal Andréa Lessa Benedet | 2024/3/1 | |
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases | Brain | Johanna Nilsson Alexa Pichet Binette Sebastian Palmqvist Wagner S Brum Shorena Janelidze | 2024/2/7 |
Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals | Alzheimer's & Dementia | Marcel S Woo Cécile Tissot Juan Lantero‐Rodriguez Anniina Snellman Joseph Therriault | 2024/2 |
Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology | eBioMedicine | Joseph Therriault Nicholas James Ashton Ilaria Pola Gallen Triana-Baltzer Wagner Scheeren Brum | 2024/4/1 |
Feasibility of Using Blood-based Biomarkers to Evaluate the Effectiveness of Individualized Neurodegenerative Disease Preventive Care (P4-9.002) | Philip Sisser Kellyann Niotis Alon Seifan Shannon Helfman Praveen Parthasarathy | 2024/4/14 | |
Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest | Critical Care | Isabelle Arctaedius Helena Levin Bergthóra Thorgeirsdóttir Marion Moseby-Knappe Tobias Cronberg | 2024/12 |
Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid Immunotherapies | JAMA neurology | Niklas Mattsson-Carlgren Lyduine E Collij Erik Stomrud Alexa Pichet Binette Rik Ossenkoppele | 2024/1/1 |
Comparison of immunoassay-with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology | Molecular Neurodegeneration | Joseph Therriault Marcel S Woo Gemma Salvadó Johan Gobom Thomas K Karikari | 2024/1/7 |
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses (vol 145, pg 4097, 2022) | Brain | Edward J Needham Alexander L Ren Richard J Digby Emma J Norton Soraya Ebrahimi | 2022/11/1 |
A novel ultrasensitive assay for plasma p‐tau217: performance in individuals with subjective cognitive decline and early Alzheimer's disease | Alzheimer's & Dementia | Fernando Gonzalez‐Ortiz Pamela CL Ferreira Armand González‐Escalante Laia Montoliu‐Gaya Paula Ortiz‐Romero | 2024/2 |
Comparison of CSF and plasma NfL and pNfH for Alzheimer’s disease diagnosis: a memory clinic study | Journal of Neurology | Agathe Vrillon Nicholas J Ashton Thomas K Karikari Karl Götze Emmanuel Cognat | 2024/3 |
Vascular risk burden is a key player in the early progression of Alzheimer’s disease | Neurobiology of Aging | João Pedro Ferrari-Souza Wagner S Brum Lucas A Hauschild Lucas U Da Ros Pâmela CL Ferreira | 2024/4/1 |
Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | Joyce R Chong Yuek Ling Chai Amelia TY Yam Saima Hilal Henri Vrooman | 2024/4 |
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease | Molecular Neurodegeneration | Juan Lantero-Rodriguez Gemma Salvadó Anniina Snellman Laia Montoliu-Gaya Wagner S Brum | 2024/12 |
CT‐based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration | Alzheimer's & Dementia | Meera Srikrishna Nicholas J Ashton Alexis Moscoso Joana B Pereira Rolf A Heckemann | 2024/1 |
The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease. | Yi-Ting Wang Nicholas J Ashton Stijn Servaes Johanna Nilsson Marcel S Woo | 2024/1/3 | |
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings | Alzheimer's & Dementia | Hanna Huber Kaj Blennow Henrik Zetterberg Mercé Boada Andreas Jeromin | 2024/1/29 |
Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season | Neurological Research and Practice | Theres Bastgen Janis Evers Christiane Oedekoven Caroline Weide Lars Herzog | 2024/2/29 |
Co-Authors
